AGT and Alzheimer disease: To illustrate the protective effect of SIL in AD, the BAPN-induced mice were intraperitoneally injected with SIL (50 mg/kg/2 days) or vehicle for 28 days, then the mice were subcutaneously infused 1000 ng/kg/min AngII for 24 h (Fig. 2B).